Neonatal Nav1.5 protein expression in normal adult human tissues and breast cancer
| Autor: | Esra Battaloglu, Christopher S. Foster, Handan Kaya, Rezan Fahrioglu Yamaci, Kamil Erguler, Scott P. Fraser, Mustafa B. A. Djamgoz |
|---|---|
| Rok vydání: | 2017 |
| Předmět: |
Male
0301 basic medicine Pathology medicine.medical_specialty Estrogen receptor Breast Neoplasms Nav1.5 NAV1.5 Voltage-Gated Sodium Channel Pathology and Forensic Medicine Metastasis 03 medical and health sciences 0302 clinical medicine Breast cancer Downregulation and upregulation In vivo Biomarkers Tumor medicine Humans Protein Isoforms skin and connective tissue diseases biology Cancer Cell Biology medicine.disease 030104 developmental biology 030220 oncology & carcinogenesis Cancer research biology.protein Biomarker (medicine) Female |
| Zdroj: | Pathology - Research and Practice. 213:900-907 |
| ISSN: | 0344-0338 |
| Popis: | Expression of the neonatal splice variant of the voltage-gated sodium channel α-subunit (VGSC) subtype Nav1.5 (nNav1.5), encoded by the gene SCN5A, was shown earlier to be upregulated in human breast cancer (BCa), both in vitro and in vivo. Channel activity promoted BCa invasion of Matrigel®in vitro and metastasis in vivo. Consequently, expression of nNav1.5 has been proposed as a functional biomarker of BCa cells with metastatic potential. Here, we have determined immunohistochemically both nNav1.5 and total VGSC (tVGSC) protein expression in a range of adult human tissues. Some VGSC protein was expressed in normal colon, small intestine, stomach, prostate, bladder and breast. As expected, high levels of VGSC protein were expressed in brain, skeletal muscle and cardiac muscle. On the other hand, nNav1.5 protein was not expressed in any of the normal tissues tested except breast where a low-level of protein was present. In comparison to normal breast, nNav1.5 protein expression in BCa was consistently widespread and occurred at a significantly higher level. We also questioned whether there was any relationship between the nNav1.5 protein expression and the estrogen receptor (ERα) status of BCa and obtained the following results. First, all cases lacking nNav1.5 were positive for ERα. Second, in all ERα-negative tissues, nNav1.5 protein was expressed in plasma membrane. Third, however, in ERα-positive cases, nNav1.5 protein expression was observed in both plasma membrane and cytoplasm. In conclusion, nNav1.5 protein has a restricted expression pattern among human tissues. High level expression occurs in BCa and associates with ERα status. These results further support the proposition that nNav1.5 is a novel biomarker of metastatic BCa. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect